相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of novel potent HIV-1 inhibitors by exploiting the tolerant regions of the NNRTIs binding pocket
Yanying Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences
Stephen K. Burley et al.
NUCLEIC ACIDS RESEARCH (2021)
Avoiding Drug Resistance in HIV Reverse Transcriptase
Maria E. Cilento et al.
CHEMICAL REVIEWS (2021)
Exploiting the tolerant region I of the non-nucleoside reverse transcriptase inhibitor (NNRTI) binding pocket. Part 2: Discovery of diarylpyrimidine derivatives as potent HIV-1 NNRTIs with high Fsp3 values and favorable drug-like properties
Xiangyi Jiang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies
Dongwei Kang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Structure-Based Design and Discovery of Pyridyl-Bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling Studies
Boshi Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of benzo[d]oxazole derivatives as the potent type-I FLT3-ITD inhibitors
Jiyin Bao et al.
BIOORGANIC CHEMISTRY (2020)
Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs
Dongwei Kang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Weak Intermolecular CH•••N Hydrogen Bonding: Determination of 13CH-15N Hydrogen-Bond Mediated J Couplings by Solid-State NMR Spectroscopy and First-Principles Calculations
Amy L. Webber et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2020)
New techniques and strategies in drug discovery
Jintong Du et al.
CHINESE CHEMICAL LETTERS (2020)
Development, synthesis and biological investigation of a novel class of potent PC-PLC inhibitors
Lisa Pilkington et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties
Dongwei Kang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Fsp(3): A new parameter for drug-likeness
Wenxiu Wei et al.
DRUG DISCOVERY TODAY (2020)
Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles
Boshi Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Ligand Potency, Efficiency and Drug-likeness: A Story of Intuition, Misinterpretation and Serendipity
Jaroslaw Polanski et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2019)
Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment
Yuqing Gong et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Molecular design opportunities presented by solvent-exposed regions of target proteins
Xiangyi Jiang et al.
MEDICINAL RESEARCH REVIEWS (2019)
Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment
Yali Wang et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Escaping from Flatland: [2+2] Photocycloaddition; Conformationally Constrained sp3-rich Scaffolds for Lead Generation
Brian Cox et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic
Vigneshwaran Namasivayam et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Challenges and approaches in the discovery of human immunodeficiency virus type-1 non-nucleoside reverse transcriptase inhibitors
Leandro Battini et al.
MEDICINAL RESEARCH REVIEWS (2019)
Colloidal Drug Aggregate Stability in High Serum Conditions and Pharmacokinetic Consequence
Ahil N. Ganesh et al.
ACS CHEMICAL BIOLOGY (2019)
Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors
Xiangyi Jiang et al.
RSC ADVANCES (2019)
Structural basis for potent and broad inhibition of HIV-1 RT by thiophene[3,2-d] pyrimidine non-nucleoside inhibitors
Yang Yang et al.
ELIFE (2018)
Novel diaryltriazines with a picolinonitrile moiety as potent HIV-1 RT inhibitors: a patent evaluation of WO2016059647(A2)
Boshi Huang et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Discovery of uracil-bearing DAPYs derivatives as novel HIV-1 NNRTIs via crystallographic overlay-based molecular hybridization
Heng Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Ligand efficiency metrics in drug discovery: the pros and cons from a practical perspective
Maria Maddalena Cavalluzzi et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
HIV Drug Resistance - An Emerging Threat to Epidemic Control
Chris Beyrer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Novel diarylpyrimidines and diaryltriazines as potent HIV-1 NNRTIs with dramatically improved solubility: a patent evaluation of US20140378443A1
Boshi Huang et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Stable Colloidal Drug Aggregates Catch and Release Active Enzymes
Christopher K. McLaughlin et al.
ACS CHEMICAL BIOLOGY (2016)
Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles
Dongwei Kang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The role of ligand efficiency metrics in drug discovery
Andrew L. Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Thermodynamics of HIV-1 Reverse Transcriptase in Action Elucidates the Mechanism of Action of Non-Nucleoside Inhibitors
Guillaume Bec et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design
Peng Zhan et al.
MEDICINAL RESEARCH REVIEWS (2013)
Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability
Iris Usach et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2013)
Carbon-Oxygen Hydrogen Bonding in Biological Structure and Function
Scott Horowitz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
MMPBSA.py: An Efficient Program for End-State Free Energy Calculations
Bill R. Miller et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
Direct observation of hydrogen atom dynamics and interactions by ultrahigh resolution neutron protein crystallography
Julian C. -H. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
MECHANISMS OF DISEASE Development of Antiretroviral Drug Resistance
Mark A. Wainberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Eastern extension of azoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase; cyano group alternatives
Cheryl S. Leung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Interacciones medicamentosas de etravirina
Vicente Estrada Pérez et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2010)
Crystal Structures of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implications for Drug Design
Eric B. Lansdon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Design Strategies of Novel NNRTIs to Overcome Drug Resistance
Peng Zhan et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Sulfanyltriazole/tetrazoles: A Promising Class of HIV-1 NNRTIs
Peng Zhan et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later
Christophe Pannecouque et al.
NATURE PROTOCOLS (2008)
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations
Kalyan Das et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Ligand efficiency indices for effective drug discovery
Cele Abad-Zapatero
EXPERT OPINION ON DRUG DISCOVERY (2007)
Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability
YV Frenkel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
CH•••O and CH•••N hydrogen bonds in ligand design:: A novel quinazolin-4-ylthiazol-2-ylamine protein kinase inhibitor
AC Pierce et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
分享论文
